Harbour BioMed Company

Harbour BioMed (HKEX: 02142.HK) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on oncology and immunology.

Funding Status: Late Stage Venture
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Technology: Others
Founded Date: 2016
Headquarters: China
Industry: Loss of Proteostasis